Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats
- PMID: 20043961
- PMCID: PMC2840186
- DOI: 10.1016/j.jconrel.2009.12.019
Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats
Abstract
The relationship between microparticle (MP) size and lung targeting efficiency, intra-lung distribution and retention time was systematically studied after intravenous administration of rigid fluorescent polystyrene MPs of various sizes (2, 3, 6 and 10 microm) to Sprague Dawley rats. Total fluorescence was assessed and it was found that 2 microm and 3 microm MPs readily passed through the lung to the liver and spleen while 10 microm MPs were completely entrapped in the lung for the one-week duration of the study. Approximately 84% of 6 microm MPs that were initially entrapped in the lung were cleared over the next 2 days and 15% were cleared over the remaining 5 days. A Caliper IVIS 100 small animal imaging system confirmed that 3 microm MPs were not retained in the lung but that 6 microm and 10 microm MPs were widely distributed throughout the lung. Moreover, histologic examination showed MP entrapment in capillaries but not arterioles. These studies suggest that for rigid MPs the optimal size range required to achieve transient but highly efficiently targeting to pulmonary capillaries after IV injection is >6 microm but <10 microm in rats and that systemic administration of optimally sized MPs may be an efficient alternative to currently used inhalation-based delivery to the lung.
Copyright 2009 Elsevier B.V. All rights reserved.
Figures





Similar articles
-
Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.Anticancer Drugs. 2010 Jan;21(1):65-76. doi: 10.1097/CAD.0b013e328332a322. Anticancer Drugs. 2010. PMID: 19966540 Free PMC article.
-
Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats.Int J Pharm. 2010 Dec 15;402(1-2):64-71. doi: 10.1016/j.ijpharm.2010.09.020. Epub 2010 Sep 29. Int J Pharm. 2010. PMID: 20883756 Free PMC article.
-
Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery.Int J Pharm. 2015 May 15;485(1-2):7-14. doi: 10.1016/j.ijpharm.2015.02.059. Epub 2015 Feb 24. Int J Pharm. 2015. PMID: 25724134 Free PMC article.
-
Tissue distribution of 20 nm, 100 nm and 1000 nm fluorescent polystyrene latex nanospheres following acute systemic or acute and repeat airway exposure in the rat.Toxicology. 2009 Sep 19;263(2-3):117-26. doi: 10.1016/j.tox.2009.07.002. Epub 2009 Jul 15. Toxicology. 2009. PMID: 19615422
-
Biodistribution of size-selected lyophilisomes in mice.Eur J Pharm Biopharm. 2015 Aug;94:141-51. doi: 10.1016/j.ejpb.2015.04.020. Epub 2015 May 5. Eur J Pharm Biopharm. 2015. PMID: 25953331
Cited by
-
Toxicodynamics of rigid polystyrene microparticles on pulmonary gas exchange in mice: implications for microemboli-based drug delivery systems.Toxicol Appl Pharmacol. 2013 Jan 15;266(2):214-23. doi: 10.1016/j.taap.2012.10.021. Epub 2012 Nov 8. Toxicol Appl Pharmacol. 2013. PMID: 23142466 Free PMC article.
-
Quantitative Pharmacokinetics Reveal Impact of Lipid Composition on Microbubble and Nanoprogeny Shell Fate.Adv Sci (Weinh). 2024 Jan;11(4):e2304453. doi: 10.1002/advs.202304453. Epub 2023 Nov 30. Adv Sci (Weinh). 2024. PMID: 38032129 Free PMC article.
-
Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates.J Control Release. 2012 Nov 28;164(1):65-73. doi: 10.1016/j.jconrel.2012.09.011. Epub 2012 Oct 3. J Control Release. 2012. PMID: 23041417 Free PMC article.
-
Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.Anticancer Drugs. 2010 Jan;21(1):65-76. doi: 10.1097/CAD.0b013e328332a322. Anticancer Drugs. 2010. PMID: 19966540 Free PMC article.
-
Microfluidic generation of droplets with a high loading of nanoparticles.Langmuir. 2012 Sep 18;28(37):13143-8. doi: 10.1021/la3025952. Epub 2012 Sep 4. Langmuir. 2012. PMID: 22934976 Free PMC article.
References
-
- Pritchard JN. The influence of lung deposition on clinical response. J Aerosol Med. 2001;14(Suppl 1):S19–26. - PubMed
-
- Derendorf H, Hochhaus G, Mollmann H. Evaluation of pulmonary absorption using pharmacokinetic methods. J Aerosol Med. 2001;14(Suppl 1):S9–17. - PubMed
-
- Washington N, Washington C, Wilson CG. Physiological pharmaceutics: barriers to drug absorption. Taylor & Francis; New York: 2001. pp. 221–247.
-
- Newman SP, Steed KP, Hooper G, Jones JI, Upchurch FC. Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler. Respir Med. 1999;93(6):424–431. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources